Changes in serum prostate specific antigen and testosterone levels after chlormadinone acetate treatment in patients with benign prostatic hyperplasia a prospective multicenter clinical study

Changes in serum prostate specific antigen and testosterone levels after chlormadinone acetate treatment in patients with benign prostatic hyperplasia : a prospective multicenter clinical study

In this prospective multicenter study, we investigated the changes in serum prostate-specific antigen (PSA) and testosterone levels after treatment with antiandrogen chlormadinone acetate (CMA) in patients with benign prostatic hyperplasia (BPH). The inclusion criteria for the patients were as follo...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 57(2011), 4 vom: 30. Apr., Seite 177-83
1. Verfasser: Fujimoto, Kiyohide (VerfasserIn)
Weitere Verfasser: Hirao, Yoshihiko, Ohashi, Yasuo, Shibata, Yasuhiro, Fuji, Kohzo, Tsuji, Hidenori, Shimizu, Nobutaka, Miyazawa, Katsuhito, Nagata, Masao, Ohtani, Nikinobu, Furuya, Ryoji, Boku, Eitetsu
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 2011
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:English Abstract Journal Article Multicenter Study Androgen Antagonists Chlormadinone Acetate 0SY050L61N Testosterone 3XMK78S47O Prostate-Specific Antigen EC 3.4.21.77